Journal
/
/
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
Journal JoVE
Bio-ingénierie
Author Produced
This content is Free Access.
Journal JoVE Bio-ingénierie
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

DOI:

10:41 min

January 23, 2021

,

Chapitres

  • 00:00Introduction
  • 00:54Cardiac Spheroid Formation
  • 05:46Drug Testing
  • 06:42Representative Results
  • 07:36Endothelial Cell Network Staining
  • 09:52Representative Results
  • 10:04Conclusion

Summary

Traduction automatique

This protocol aims to fabricate 3D cardiac spheroids (CSs) by co-culturing cells in hanging drops. Collagen-embedded CSs are treated with doxorubicin (DOX, a cardiotoxic agent) at physiological concentrations to model heart failure. In vitro testing using DOX-treated CSs may be used to identify novel therapies for heart failure patients.

Vidéos Connexes

Read Article